Studies on the adrenergic receptor specificity of inhibitors of phenylethanolamine N-methyltransferase.
We have examined a series of potent PNMT inhibitors for their selectivity on this enzyme vis'-a-vis other adrenergic receptors for which norepinephrine is also an agonist or substrate. The parent compound, SK&F 64139, inhibits PNMT in the nanomolar range and also has moderate affinity as an alpha 2-adrenoceptor antagonist. Moreover, it possesses very weak activity as an MAO inhibitor and alpha 1-adrenoceptor antagonist. With other compounds in the series, it was possible to retain marked PNMT inhibitory activity while substantially decreasing alpha 2-blocking affinity. These drugs, however, have greater central nervous system (CNS) toxicity than SK&F 64139. It was also possible to substantially enhance the PNMT inhibitory activity of a highly polar compound (SK&UF 29661) without decreasing its receptor specificity, although the resulting analogue contains an additional lipophilic chloro substituent and does, unlike SK&F 29661, penetrate into the CNS.